May argyrophilic nucleolar organizing region-associated protein synthesis be used for selecting the most reliable dose of drugs such as rhamnetin in cancer treatments?

Creative Commons License

ERTEKIN T., Bozkurt O., Eroz R., NİSARİ M., Bircan D., Nisari M., ...Daha Fazla

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, cilt.117, sa.11, ss.653-658, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 117 Sayı: 11
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4149/bll_2016_126
  • Dergi Adı: BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.653-658
  • Anahtar Kelimeler: NOR, AgNORs, rhamnetin, cancer treatments, rDNA, CELLS, CAROTENOIDS, EXPRESSION, FLAVONOIDS, PREVENTION, AREA, NORS, AGE
  • Erciyes Üniversitesi Adresli: Evet

Özet

BACKGROUND: Rhamnetin is a flavonoid that has antioxidant, anti-inflammatory and anti-cancer effects. Nucleolar-organizing regions are the ribosomal genes region. We aimed to identify whether rhamnetin has an effect on cell proliferation and whether AgNOR proteins may be used for the detection of therapeutic benefits of the drugs and new metabolites, which have the potential of being used for cancer treatments.